Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Grifols SA opens facility in Clayton, NC to help advance treatment of rare and life-threatening diseases


Tuesday, 17 Jun 2014 09:00am EDT 

Grifols SA:Opening of new North Fractionation Facility (NFF) in Clayton, NC, where production capacity of plasma will almost double to about 6 mln liters annually.Grifols' products are used to treat rare, chronic diseases such as a neurological disorder, immune deficiencies, hemophilia and genetic emphysema. 

Company Quote

35.825
-0.49 -1.35%
28 Nov 2014